FDA Drug Safety Communication: Safety Review of possible increased risk of blood clots with birth control pills containing drospirenone

[05-31-2011] The U.S. Food and Drug Administration (FDA) is informing the public about new information that is being assessed as part of FDA ' s ongoing safety review of birth control pills that contain drospirenone.
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Source Type: news